However, Birkeland et al. (35) found a high rate of CRTC1/3-MAML2 gene fusions in a large cohort of MEC patients, but the authors did not note any correlation between fusion status and tumor grade or survival. Here, MAML2 is linked to mucoepidermoid carcinoma.